| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 30 Sep 2025 | 3 Sep 2025 |
| Beta Drugs Limited has informed the Exchange regarding Beta Drugs Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 24-Sep-2025 to 30-Sep-2025 for the purpose of ANNUAL GENERAL MEETING to be held on 30.09.2025 Beta Drugs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2025 (As Per NSE Announcement Dated On : 30.09.2025) Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2025. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated On : 01.10.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.